UK Markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
7.24-4.76 (-39.67%)
At close: 07:12PM GMT

Invitae Corporation

1400 16th Street
San Francisco, CA 94103
United States
415 374 7782

Full-time employees2,900

Key executives

NameTitlePayExercisedYear born
Dr. Sean Emerson George Ph.D.Co-Founder, Pres, CEO & Director451.35k625.9k1974
Mr. Kenneth D. KnightChief Operating Officer428.5kN/A1961
Mr. Lee BendekgeyChief Policy Officer383.64k2.07M1958
Ms. Yafei WenChief Financial OfficerN/AN/A1972
Mr. Robert F. WernerChief Accounting Officer & Principal Accounting OfficerN/AN/A1973
Mr. Karthik SuriChief Product & Technology OfficerN/AN/AN/A
Ms. Laura D'AngeloHead of Investor RelationsN/AN/AN/A
Dr. Robert L. NussbaumChief Medical OfficerN/AN/A1950
Glenn MedalleHead of TalentN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. It has a collaboration with Pacific Biosciences of California, Inc. to develop a production-scale high-throughput HiFi sequencing platform. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.

Corporate governance

Invitae Corporation’s ISS governance QualityScore as of 26 September 2021 is 6. The pillar scores are Audit: 6; Board: 3; Shareholder rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.